Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview
Fentanyl citrate remains among the most crucial tools in modern-day anaesthesia and acute discomfort management across the United Kingdom. As a potent artificial opioid, its function in the National Health Service (NHS) and personal surgical sectors is reputable, mostly due to its rapid beginning of action and cardiovascular stability. This article supplies a comprehensive overview of fentanyl citrate injection solutions available in the UK, their clinical signs, regulative landscape, and administration protocols.
What is Fentanyl Citrate?
Fentanyl citrate is a potent phenylpiperidine-derivative opioid agonist. It was first manufactured in 1960 and rapidly became a cornerstone of perioperative care. In terms of strength, fentanyl is roughly 50 to 100 times more potent than morphine. Its high lipophilicity permits it to cross the blood-brain barrier rapidly, resulting in an almost immediate analgesic impact when administered intravenously.
In the UK, fentanyl citrate is predominantly utilized by means of the parenteral route (injection) for both sedative and analgesic purposes. It works primarily by binding to the mu-opioid receptors in the central nerve system, changing the perception of pain and the psychological action to it.
Scientific Indications in the UK
According to the British National Formulary (BNF), fentanyl citrate injection is suggested for numerous particular scientific scenarios:
- Analgesic Action: Used during short personnel procedures and in the healing room.
- Analgesic Supplement: Used throughout the induction and maintenance of inhalation anaesthesia.
- Neuroleptanalgesia: Often utilized in combination with a neuroleptic (such as droperidol) to attain a state of quiescence and lowered awareness.
- Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
- Pre-medication: To provide sedation and analgesia before the induction of general anaesthesia.
Offered Formulations and Strengths in the UK
The UK market uses a number of solutions of fentanyl citrate, developed to satisfy the differing needs of surgical and emergency situation departments. Fentanyl Suppliers UK are generally provided as clear, colourless services for injection or infusion.
Table 1: Common Fentanyl Citrate Formulations in the UK
| Strength (Fentanyl base) | Presentation | Common Packaging | Maker Examples |
|---|---|---|---|
| 50 micrograms/ml | 2 ml Ampoule | Pack of 10 | Hameln, Advanz Pharma |
| 50 micrograms/ml | 10 ml Ampoule | Pack of 5 or 10 | Hameln, Wockhardt |
| 50 micrograms/ml | 20 ml Vial/Ampoule | Load of 5 | Hameln, Generic |
| 50 micrograms/ml | 50 ml Vial | Individual/Pack of 1 | Generic (ICU use) |
Note: While 50 mcg/ml is the standard concentration, specialised formulas for epidural or intrathecal usage might in some cases be prepared by medical facility pharmacies under specific protocols.
Pharmacokinetics and Pharmacodynamics
Understanding how the body processes fentanyl is crucial for safe administration.
- Onset of Action: When administered intravenously, the effect begins practically right away, though the optimum analgesic impact might take 3 to 5 minutes.
- Period: A single intravenous dose of 100 micrograms generally lasts for 30 to 60 minutes.
- Metabolic process: Fentanyl is mainly metabolised in the liver via the CYP3A4 enzyme system.
- Excretion: Approximately 75% of the dose is excreted in the urine within 24 hours, mostly as metabolites.
Administration Protocols
In the UK, the administration of fentanyl citrate is strictly managed and usually performed by anaesthetists or trained specialists in controlled environments.
Dosage Guidelines
Dosage needs to be horizontal and individualised based on the client's age, weight, physical status, underlying pathological condition, use of other drugs, and the type of surgical treatment.
- Low Dose (2 mcg/kg): Useful for small surgical treatments.
- Moderate Dose (2-- 20 mcg/kg): Used when surgery is more invasive; needs breathing tracking.
- High Dose (20-- 50 mcg/kg): Used during "trouble-free" major surgeries (e.g., open-heart surgical treatment) to secure the myocardium from the metabolic demands of tension.
Routes of Administration
- Intravenous (IV) Bolus: Common for induction.
- Intravenous Infusion: Used for longer procedures or in the ICU.
- Intramuscular (IM): Less typical, however utilized for pre-medication in particular circumstances.
Regulative Status and Safety
In the United Kingdom, Fentanyl is classified under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is categorized as a Schedule 2 Controlled Drug (CD POM).
Statutory Requirements for UK Hospitals:
- Safe Custody: Must be stored in a locked managed drug cabinet.
- Record Keeping: Every administration should be taped in a Controlled Drugs Register (CDR).
- Damage: Surplus or expired fentanyl should be denatured and witnessed by authorised workers.
Negative Effects and Adverse Reactions
While extremely effective, fentanyl citrate brings a threat of substantial side effects.
- Respiratory Depression: The most severe negative effects, which can result in respiratory arrest if not kept an eye on.
- Bradychardia: Often managed with atropine.
- Muscle Rigidity (Chest Wall Rigidity): High dosages can make ventilation hard, requiring using neuromuscular obstructing agents.
- Nausea and Vomiting: Common in the postoperative duration.
- Hypotension: Although more stable than morphine, it can still happen, specifically in hypovolaemic patients.
Contrast with Other Opioids
Clinicians often select fentanyl over other opioids due to its particular pharmacokinetic profile.
Table 2: Comparison of Parenteral Opioids in UK Practice
| Function | Fentanyl | Morphine | Remifentanil |
|---|---|---|---|
| Relative Potency | 100 | 1 | 100-200 |
| Start | 1-- 3 minutes | 15-- 30 minutes | 1 minute |
| Period of Action | 30-- 60 minutes | 3-- 4 hours | 5-- 10 minutes |
| Histamine Release | Negligible | Substantial | Minimal |
| Main Use | Intraoperative/ICU | Post-operative/Chronic | Titratable Infusion |
Regularly Asked Questions (FAQ)
1. Is fentanyl citrate injection the very same as the fentanyl spots?
No. While they include the exact same active drug, the injection is for instant, severe use in surgical or emergency settings. Patches (transdermal shipment) are designed for chronic, long-term discomfort management and launch the medication slowly over 72 hours.
2. Can fentanyl citrate be used for children in the UK?
Yes, it is frequently used in paediatric anaesthesia. However, the dose needs to be strictly calculated based on the child's weight, and they need to be kept an eye on closely for breathing depression.
3. What is the antagonist for fentanyl?
Naloxone is the specific pharmacological antagonist utilized to reverse the results of fentanyl, consisting of breathing anxiety. In UK healthcare facilities, naloxone should constantly be readily offered any place fentanyl is administered.
4. Why is it utilized over morphine in heart surgical treatment?
Fentanyl is chosen in heart surgical treatment because it does not cause the release of histamine, which can cause vasodilation and hypotension. It provides cardiovascular stability even at high doses.
5. What are the storage requirements?
Fentanyl citrate injection must be kept below 25 ° C and protected from light. As a Schedule 2 drug, it must be kept in a legally compliant CD cabinet.
Fentanyl citrate injection formulas are essential elements of the UK's medical toolkit for managing perioperative discomfort and assisting in intricate surgeries. Its high strength and rapid onset offer unequaled accuracy for anaesthetists, supplied that rigorous tracking and regulatory requirements are maintained. By understanding the numerous concentrations and the stringent protocols surrounding its usage, healthcare specialists ensure that this powerful medication remains both safe and effective for patients across the nation.
Disclaimer: This short article is for educational functions only and does not constitute medical recommendations. Healthcare professionals must always describe the Summary of Product Characteristics (SmPC) and existing BNF standards for the most current recommending information.
